Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adamantane SCHEMBL29707714 | 0.68 | CYP2C9 (0.46) | CYP2C9EPHX2HSD11B1 | |
| Adamantane SCHEMBL12761 | 0.68 | CYP2C9 (0.46) | CYP2C9EPHX2HSD11B1 | |
| Adamantane SCHEMBL9016497 | 0.68 | CYP2C9 (0.46) | CYP2C9EPHX2HSD11B1 | |
| Adamantane SCHEMBL1527414 | 0.68 | CYP2C9 (0.46) | CYP2C9EPHX2HSD11B1 | |
| SCHEMBL2189873 | 0.67 | CYP2C9 (0.50) | CYP2C9EPHX2HSD11B1CYP2A13CA1 | |
| SCHEMBL10459155 | 0.64 | CYP2C9 (0.47) | CYP2C9EPHX2HSD11B1CYP2A13CA1 | |
| Adamantane SCHEMBL25252048 | 0.63 | CYP2C9 (0.43) | CYP2C9EPHX2 | |
| Adamantane SCHEMBL21067465 | 0.63 | CYP2C9 (0.43) | CYP2C9EPHX2 | |
| Adamantane SCHEMBL21192802 | 0.63 | CYP2C9 (0.43) | CYP2C9EPHX2 | |
| Adamantane SCHEMBL21820021 | 0.63 | CYP2C9 (0.43) | CYP2C9EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8778510-B2 | Pyrromethene-boron complex compounds and organic electroluminescent elements using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-15 | — | — | US | disclosed |
| EP-2402351-B1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTRO- LUMINESCENT ELEMENTS USING SAME | IDEMITSU KOSAN CO (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130001472-A1 | THIN FILM AND COMPOUND USED IN THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-03 | — | — | US | disclosed |
| US-20120211706-A1 | POLYDENTATE LIGAND METAL COMPLEX | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120049167-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-01 | — | — | US | disclosed |
| EP-2423192-A1 | METAL COMPLEX HAVING AROMATIC LIGAND THAT CONTAINS NITROGEN ATOM | Sumitomo Chemical Company, Limited (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20120037890-A1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME | MITSUI CHEMICALS, INC. | 2012-02-16 | — | — | US | disclosed |
| EP-2402351-A1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTRO- LUMINESCENT ELEMENTS USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2012-01-04 | — | — | EP | disclosed |
| EP-2383814-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Sumitomo Chemical Company, Limited (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-7371503-B2 | Sulfonium salt compound, photoacid generator, and positive-tone radiation-sensitive resin composition | JSR CORPORATION (JP) | 2008-05-13 | — | — | US | disclosed |
| US-20060141383-A1 | Sulfonium salts, radiation- sensitive acid generators, and positive radiator-sensitive resin compositions | JSR CORPORATION (JP) | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120037890-A1 | PYRROMETHENE-BORON COMPLEX COMPOUNDS AND ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME | LEF1, ZRANB2, AFF1 | CYP2C9 1451/4885EPHX2 2681/4885HSD11B1 1080/4885 |
| US-20120041203-A1 | METAL COMPLEX HAVING AROMATIC RING LIGAND CONTAINING NITROGEN ATOM | MICA, CD4, CLTC | CYP2C9 3539/4885EPHX2 4657/4885HSD11B1 4313/4885 |
| US-20130001472-A1 | THIN FILM AND COMPOUND USED IN THE SAME | NR2E3, NR3C1, NR0B2 | CYP2C9 3895/4885EPHX2 2673/4885HSD11B1 1196/4885 |
| US-20120211706-A1 | POLYDENTATE LIGAND METAL COMPLEX | CAD, SLC7A5, PICALM | CYP2C9 4178/4885EPHX2 4398/4885HSD11B1 4776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.